Is It Finally OK to Buy Bristol-Myers Squibb?
January 24, 2017 at 08:21 AM EST
While stumbles in lung cancer trials have taken Bristol-Myers Squibb share price lower, investors might want to consider this company's stock to be on sale.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.